Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald F Watts

Showing results (41-50 of 706) with videos related to

Pageof 71
Sort By:
The Medical Journal of Australia|September 2, 2016
Progress in the care of familial hypercholesterolaemia: 2016Damon A Bell, Gerald F Watts
Cardiology Clinics|April 4, 2018
Is Lipoprotein(a) Ready for Prime-Time Use in the Clinic?Katrina L Ellis, Gerald F Watts
Current Opinion in Endocrinology, Diabetes, and Obesity|February 26, 2026
The future of triglyceride-regulating therapies and registriesGerald F Watts, Dick C Chan
Journal of the American College of Cardiology|May 2, 2020
Atherogenic Dyslipoproteinemia and Management of ASCVD: Will New Indices Untie the Gordian Knot?Gerald F Watts, Dick C Chan
Current Opinion in Lipidology|April 30, 2020
Metabolism of lipoprotein(a): new findings, implications and outstanding issuesDick C Chan, Gerald F Watts
Drugs|September 16, 2015
Challenges in the Diagnosis and Treatment of Homozygous Familial HypercholesterolemiaMatthew K Ito, Gerald F Watts
Expert Opinion on Drug Metabolism & Toxicology|August 22, 2015
Evolocumab in the treatment of dyslipidemia: pre-clinical and clinical pharmacologyMichael M Page, Gerald F Watts
Current Opinion in Endocrinology, Diabetes, and Obesity|February 24, 2022
Microplastics, cardiometabolic risk, genetics and Alzheimer's diseaseGerald F Watts, Dick C Chan
Journal of Clinical Lipidology|June 28, 2018
PCSK9 monoclonal antibody on a knife-edge: An article of faith in FH?Natalie C Ward, Gerald F Watts
Atherosclerosis|January 16, 2019
Simon Broome confirms that the IAS definition of severe familial hypercholesterolemia predicts coronary mortality in patients with FHRaul D Santos, Gerald F Watts
Pageof 71

Showing results (41-50 of 706) with videos related to

Sort By:
Pageof 71
The Medical Journal of Australia|September 2, 2016
Progress in the care of familial hypercholesterolaemia: 2016Damon A Bell, Gerald F Watts
Cardiology Clinics|April 4, 2018
Is Lipoprotein(a) Ready for Prime-Time Use in the Clinic?Katrina L Ellis, Gerald F Watts
Current Opinion in Endocrinology, Diabetes, and Obesity|February 26, 2026
The future of triglyceride-regulating therapies and registriesGerald F Watts, Dick C Chan
Journal of the American College of Cardiology|May 2, 2020
Atherogenic Dyslipoproteinemia and Management of ASCVD: Will New Indices Untie the Gordian Knot?Gerald F Watts, Dick C Chan
Current Opinion in Lipidology|April 30, 2020
Metabolism of lipoprotein(a): new findings, implications and outstanding issuesDick C Chan, Gerald F Watts
Drugs|September 16, 2015
Challenges in the Diagnosis and Treatment of Homozygous Familial HypercholesterolemiaMatthew K Ito, Gerald F Watts
Expert Opinion on Drug Metabolism & Toxicology|August 22, 2015
Evolocumab in the treatment of dyslipidemia: pre-clinical and clinical pharmacologyMichael M Page, Gerald F Watts
Current Opinion in Endocrinology, Diabetes, and Obesity|February 24, 2022
Microplastics, cardiometabolic risk, genetics and Alzheimer's diseaseGerald F Watts, Dick C Chan
Journal of Clinical Lipidology|June 28, 2018
PCSK9 monoclonal antibody on a knife-edge: An article of faith in FH?Natalie C Ward, Gerald F Watts
Atherosclerosis|January 16, 2019
Simon Broome confirms that the IAS definition of severe familial hypercholesterolemia predicts coronary mortality in patients with FHRaul D Santos, Gerald F Watts
Pageof 71